Cannabinoid · Endocannabinoid
Anandamide (AEA) was the first endocannabinoid ever discovered, in 1992: a molecule your own body makes that binds the same CB1 receptor as THC. Its name comes from the Sanskrit ananda, “bliss.” It is built on demand from fatty acids and broken down within minutes by the enzyme FAAH, so its effects are brief and local.
The body’s own cannabinoid
Why it matters
Anandamide is a partial agonist at CB1 and CB2, involved in mood, appetite, pain and the “runner’s high.” Because THC mimics it at CB1, anandamide is the natural counterpart that explains how a plant compound can act on the human brain at all. Drugs that block FAAH (its breakdown enzyme) raise anandamide levels and are studied for anxiety and pain.1
Biosynthesis, FAAH Hydrolysis & Receptor Pharmacology
Unlike plant phytocannabinoids stored in glandular trichomes, N-arachidonoylethanolamine (anandamide, AEA) is synthesized on demand from membrane N-arachidonoyl phosphatidylethanolamine (NAPE) via phospholipase D (NAPE-PLD) in response to intracellular calcium elevation. Foundational isolation studies by Devane, Mechoulam et al. in Science (1992, PubMed PMID 1470919), chemical characterization in NCBI PubChem (Anandamide, CID 5281969), and clinical neuropharmacology reviews in CNS & Neurological Disorders (Scherma et al., 2019, PMC6460372) demonstrate that AEA acts as a low-efficacy partial agonist at central CB1 receptors, a weak partial agonist at peripheral CB2 receptors, and a full agonist at vanilloid TRPV1 ion channels. Intracellular fatty acid amide hydrolase (FAAH) rapidly cleaves anandamide into arachidonic acid and ethanolamine, distinguishing its short-lived synaptic signaling from the prolonged hepatic metabolism of oral THC into THC-COOH.
Frequently Asked Questions
What is anandamide (AEA) and how does the body produce it?
Anandamide (N-arachidonoylethanolamine) is an endogenous fatty acid neurotransmitter synthesized on demand from cell-membrane phospholipids by the enzyme NAPE-PLD and degraded within minutes by FAAH.
How does anandamide differ from plant-derived Delta-9-THC?
Both molecules are partial agonists at the CB1 receptor, but anandamide acts locally and is broken down within minutes by FAAH, whereas exogenous Delta-9-THC resists FAAH hydrolysis and produces sustained systemic signaling.
Which receptors does anandamide activate besides CB1?
In addition to CB1 and CB2 cannabinoid receptors, anandamide is an endogenous ligand (endovanilloid) at TRPV1 ion channels and nuclear PPAR receptors.
Sources & Institutional References
- Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992). "Isolation and structure of a brain constituent that binds to the cannabinoid receptor." Science, 258(5090), 1946-1949. PubMed PMID 1470919.
- National Center for Biotechnology Information (2024). "PubChem Compound Summary for CID 5281969, Anandamide." NCBI PubChem CID 5281969.
- Scherma, M., Masia, P., Satta, V., Fratta, W., Fadda, P., & Tanda, G. (2019). "Brain activity of anandamide: a rewarding bliss?" Acta Pharmacologica Sinica, 40(3), 309-323. PMC6460372.